Rheumatoid arthritis

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease

Ann Rheum DisPublished Prospective cohort study

Authors' conclusion

2W plasmablast depletion on HSFC is strongly linked to 5-year RTX retention, while incomplete memory B-cell depletion characterises poly-refractory RA.

Study context

Population
Rituximab (RTX)-treated rheumatoid arthritis (RA) adults, from good initial RTX responders to poly-refractory RA
Participants
232 adults
Outcome
Complete depletion of B-cell subsets (naïve, memory B cells, plasmablasts; counts < 0.1 cells/µL) on high-sensitivity flow cytometry (HSFC), and association with 1-year response and 5-year RTX persistence
Follow-up
2 weeks
Methodological detailssingle-centre, real-world cohort
  • Single-centre
  • Real-world cohort

Main finding

As reported in the abstract

2W complete depletion, naïve B cells
91%
2W complete depletion, memory B cells
92%
2W complete depletion, plasmablasts
69%
Higher 2W plasmablast counts and 1-year response, OR
0.50 (95%CI 0.32-0.75; P = .001)
Higher 2W plasmablast counts and 5-year RTX persistence, OR
0.48 (95%CI 0.30-0.79; P = .004)

Observational data: associations, not effects.

Further findings

Poly-refractory RA: 2W memory B-cell counts and increasing refractoriness · 2 weeks

Memory B-cell counts and increasing refractoriness, OR
1.9 (95%CI 1.3-2.9; P = .003)
Poly-refractory RA (n=31; 13%) showed higher 2W memory B-cell levels

B-cell trajectories across multiple RTX cycles

Sustained suppression of memory B cells and plasmablasts in patients showing RTX persistence

Original publication

High-sensitivity flow cytometry in rheumatoid arthritis shows that early B-cell subset depletion is linked to 5-year rituximab response, while failure to deplete B cells occurs early in subsequent poly-refractory disease. Ann Rheum Dis. Published 11 August 2026. doi:10.1016/j.ard.2026.07.012

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.